DE69917245T2 - Betablocker enthaltende ophtalmische zusammensetzungen - Google Patents

Betablocker enthaltende ophtalmische zusammensetzungen Download PDF

Info

Publication number
DE69917245T2
DE69917245T2 DE69917245T DE69917245T DE69917245T2 DE 69917245 T2 DE69917245 T2 DE 69917245T2 DE 69917245 T DE69917245 T DE 69917245T DE 69917245 T DE69917245 T DE 69917245T DE 69917245 T2 DE69917245 T2 DE 69917245T2
Authority
DE
Germany
Prior art keywords
betablocker
ophtalmic
compositions containing
composition
blocker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69917245T
Other languages
English (en)
Other versions
DE69917245D1 (de
Inventor
Florence Maurin
Elisabeth Latour
Claude Coquelet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Chauvin SAS
Original Assignee
Laboratoires Chauvin SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Chauvin SAS filed Critical Laboratoires Chauvin SAS
Publication of DE69917245D1 publication Critical patent/DE69917245D1/de
Application granted granted Critical
Publication of DE69917245T2 publication Critical patent/DE69917245T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69917245T 1998-04-09 1999-03-17 Betablocker enthaltende ophtalmische zusammensetzungen Expired - Lifetime DE69917245T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9804489A FR2777189B1 (fr) 1998-04-09 1998-04-09 Composition ophtalmique comprenant un beta-bloquant
PCT/FR1999/000612 WO1999052559A1 (fr) 1998-04-09 1999-03-17 COMPOSITION OPHTALMIQUE COMPRENANT UN β-BLOQUANT

Publications (2)

Publication Number Publication Date
DE69917245D1 DE69917245D1 (de) 2004-06-17
DE69917245T2 true DE69917245T2 (de) 2004-10-21

Family

ID=9525090

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69917245T Expired - Lifetime DE69917245T2 (de) 1998-04-09 1999-03-17 Betablocker enthaltende ophtalmische zusammensetzungen

Country Status (14)

Country Link
US (1) US6399605B1 (de)
EP (1) EP1067966B1 (de)
JP (1) JP3725783B2 (de)
KR (1) KR100397622B1 (de)
CN (1) CN1139403C (de)
AT (1) ATE266423T1 (de)
AU (1) AU2842199A (de)
CA (1) CA2324887C (de)
DE (1) DE69917245T2 (de)
DK (1) DK1067966T3 (de)
ES (1) ES2221740T3 (de)
FR (1) FR2777189B1 (de)
PT (1) PT1067966E (de)
WO (1) WO1999052559A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS137402A0 (en) * 2002-03-26 2002-05-09 Fujisawa Pharmaceutical Co., Ltd. Novel tricyclic compounds
US20060142270A1 (en) * 2004-12-23 2006-06-29 Kowa Co., Ltd. Preventing or treating agent for glaucoma
TWI367098B (en) 2004-12-23 2012-07-01 Kowa Co Treating agent for glaucoma
JP2006298907A (ja) * 2005-03-22 2006-11-02 Teika Seiyaku Kk 点眼剤
WO2008088612A1 (en) * 2006-12-20 2008-07-24 Bausch & Lomb Incorporated Method of stimulating the production of mucin in the eye of a patient
US7659259B2 (en) * 2006-12-21 2010-02-09 Bausch & Lomb Incorporated Method of treating inflammation of the eye
US8673937B2 (en) * 2008-04-23 2014-03-18 Otsuka Pharmaceutical Co., Ltd. Eye-drop preparation and use thereof
CN102099037A (zh) * 2008-07-25 2011-06-15 旭化成制药株式会社 含有磺酰胺化合物的稳定的水溶液组合物
JP5420877B2 (ja) * 2008-10-07 2014-02-19 テイカ製薬株式会社 眼科用剤
TW201210584A (en) 2010-08-18 2012-03-16 Alcon Res Ltd Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
WO2012026609A1 (ja) 2010-08-27 2012-03-01 わかもと製薬株式会社 点眼用水性組成物
WO2018038102A1 (en) * 2016-08-23 2018-03-01 Otsuka Pharmaceutical Co., Ltd. Ophthalmic pharmaceutical composition with improved preservative effectiveness or light stability
JP6963651B2 (ja) 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
AU5084693A (en) * 1993-08-20 1995-03-21 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
IL114193A (en) * 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
SE9603480L (sv) * 1996-09-23 1998-03-24 Johan Carlfors Beredningsform för svårlösliga läkemedel

Also Published As

Publication number Publication date
FR2777189B1 (fr) 2001-04-06
ATE266423T1 (de) 2004-05-15
KR100397622B1 (ko) 2003-09-13
DE69917245D1 (de) 2004-06-17
CN1297359A (zh) 2001-05-30
CA2324887A1 (fr) 1999-10-21
CA2324887C (fr) 2007-08-07
ES2221740T3 (es) 2005-01-01
US6399605B1 (en) 2002-06-04
AU2842199A (en) 1999-11-01
KR20010042512A (ko) 2001-05-25
JP3725783B2 (ja) 2005-12-14
EP1067966A1 (de) 2001-01-17
WO1999052559A1 (fr) 1999-10-21
PT1067966E (pt) 2004-08-31
CN1139403C (zh) 2004-02-25
EP1067966B1 (de) 2004-05-12
DK1067966T3 (da) 2004-06-07
JP2002511430A (ja) 2002-04-16
FR2777189A1 (fr) 1999-10-15

Similar Documents

Publication Publication Date Title
DE69917245T2 (de) Betablocker enthaltende ophtalmische zusammensetzungen
CA2411373A1 (en) Stable liquid enzyme compositions with enhanced activity
HUP9802456A2 (hu) Biológiailag lebontható textillágyító készítmények javított parfüm tartóssággal
DE602004019780D1 (de) Eugnis
BR9714453A (pt) as,espessadas
DE60024581D1 (de) 6-phenylphenanthridine mit pde-iv hemmender wirkung
ATE329000T1 (de) Verbesserungen bei flüssigen waschmitteln
DE60110438D1 (de) Zusammensetzungen enthaltend stilbenoide mit einer hypoglykämischen wirkung
TR199801877T2 (xx) Kumaş yumuşatıcı eldesi için konsantre, dengeli ön-karışım.
IT1247945B (it) Agente avente attivita' batteriostatica e battericida
TR200200263T2 (tr) Yeni seçiçi retinoid agonistleri
ATE461276T1 (de) Enzymstabilisierung
DE60019894D1 (de) Phenantrhridin-n-oxides mit pde-iv hemmender wirkung
BR9911236B1 (pt) soluÇço e mÉtodo de limpeza.
DE50002744D1 (de) Verfahren zur herstellung von wässrig-alkalischen lösungen reduzierter indigoider farbstoffe
DE60025327D1 (de) 6-arylphenanthridine mit pde-iv hemmender wirkung
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
ATE316132T1 (de) Flüssigwaschmittel mit verbesserter alpha-amylase-enzymstabilität
DE69621146D1 (de) Verwendung von Galactanase in Tierfutter
DE50013786D1 (de) Polyurethanharnstofffasern mit erhöhter festigkeit
GT200200219A (es) Bencimidazoles
EA200200486A1 (ru) Пероральный раствор, содержащий галантамин и подсластитель
ATE259845T1 (de) Bildung von superabsorbierendem polymer
NO20001460L (no) Alkoholatholdig rengjøringsmiddel
PT1280779E (pt) Novos indanilimidazois policiclicos com actividade adrenergica alfa2

Legal Events

Date Code Title Description
8364 No opposition during term of opposition